Bioartificial Pancreas
1993; Wiley; Volume: 10; Issue: 2 Linguagem: Romeno
10.1111/j.1464-5491.1993.tb00025.x
ISSN1464-5491
Autores Tópico(s)Diabetes and associated disorders
ResumoDiabetic MedicineVolume 10, Issue 2 p. 105-109 Bioartificial Pancreas Gérard Reach, Corresponding Author Gérard Reach INSERM U341, Biomedical Engineering and Diabetes Mellitus Service de Diabétologie, Hôtel-Dieu, Paris, FranceINSERM U341, Service de Diabétologie, Hôtel-Dieu, 1 Place du Parvis Notre Dame, 75004 Paris, France.Search for more papers by this author Gérard Reach, Corresponding Author Gérard Reach INSERM U341, Biomedical Engineering and Diabetes Mellitus Service de Diabétologie, Hôtel-Dieu, Paris, FranceINSERM U341, Service de Diabétologie, Hôtel-Dieu, 1 Place du Parvis Notre Dame, 75004 Paris, France.Search for more papers by this author First published: March 1993 https://doi.org/10.1111/j.1464-5491.1993.tb00025.xCitations: 31AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References 1 Reach G.. Immunoprotected islet of Langerhans. In: J. Pickup, ed. Biotechnology of Insulin Therapy. Oxford: Blackwell Scientific. 1991: 75–96. 2 Williams PW. Notes on diabetes treated with extract and by graft of sheep pancreas. Br Med J 1884; 2: 1303–1304. 3 Sutherland DER. Report from the International Pancreas Transplant Registry. Diabetologia 1991; 34 (suppl): S28–S39. 4 Sibley RK, Sutherland DER, Goetz FC, Michael AF. Recurrent diabetes mellitus in the pancreas iso- and allograft. A light and electron microscopic and immunohis-tochemical analysis of four cases. Lab Invest 1985; 53: 132–140. 5 Tydén G., Nyberg G., Persson N., Wahlberg J.. How large is the demand for simultaneous pancreas and kidney transplantation? Transplant Proceedings 1992; 24: 778–779. 6 Lefèbvre PJ. Pancreatic transplantation: why, when and who? Diabetologia 1992; 35: 494–497. 7 Hourmant M., Murat A., Cantarovich D., Soullilou JP. Faut il étendre les indications des greffes pancréatiques chez les patients diabétiques insulino-dépendants? Diabete Metab 1991; 17: 428–432. 8 Lacy PE, Kostyanovsky M.. Method for the isolation of intact islets of Langerhans from the rat pancreas. Diabetes 1967; 16: 35–39. 9 Ricordi C., Lacy PE, Finke EH, Olack BJ, Scharp DW. Automated method for isolation of human pancreatic islets. Diabetes 1988; 37: 413–420. 10 International Islet Transplant Registry, Newsletter 1, May 1991. 11 Ricordi C., Tzakis AG, Carroll PB, Zeng Y., Rilo HL, Alejandro R., et al. Human islet isolation and allotransplantation in 22 consecutive cases. Transplantation 1992; 53: 407–414. 12 Warnock GL, Kneteman NM, Ryan EA, Rabinovitch A., Rajotte RV. Long term follow-up after transplantation of insulin-producing pancreatic islets into patients with Type 1 (insulin dependent) diabetes mellitus. Diabetologia 1992; 35: 89–95. 13 Socci C., Falqui L., Davalli AM, Ricordi C., Braghi S., Bertuzzi F., et al. Fresh human islet transplantation to replace pancreatic endocrine function in type 1 diabetic patients: Report of six cases. Acta Diabetologica 1991; 28: 151–157. 14 Altman JJ, Tessier C., Bethoux JP, Cugnenc PH, Legrelle M., Journois D., et al. Human islet cotransplantation with liver or kidney. Transplant Proc 1992; 24: 967–968. 15 Nieckrasz M., Ye Y., Rolf LL, Zuhdi N., Cooper DKC. The pig as organ donor for man. Transplant Proc 1992; 24: 625–626. 16 McLear M., Marchetti P., Finke E., Gerasimidi-Vaseou A., Scharp DW, Lacy PE. Porcine islet function: effects of arginine, leucine and butyrate. Transplant Proc 1992; 24: 980–982. 17 Andersson A., Groth CG, Korsgren O., Tibell A., Tollemar J., Kumagai M., et al. Transplantation of porcine fetal islet-like cell clusters to three diabetic patients. Transplant Proc 1992; 24: 677–678. 18 Posselt AM, Barker CF, Markmann JF, Roark JH, Naji A.. Successful islet transplantation in the thymus of spontaneously diabetic BB rats. Transplant Proc 1992; 24: 1023–1024. 19 Theodorou NA, Vrbova H., Tyhurst M., Howell SL. Problems in the use of polycarbonate diffusion chambers for syngeneic pancreatic islet transplantation in rats. Diabetologia 1980; 13: 313–317. 20 Lim F., Sun AM. Microencapsulated islets as bioartificial endocrine pancreas. Science 1980; 210: 908–910. 21 Chicheportiche D., Reach G.. Kinetics of insulin release by microencapsulated islets: effect of the size of the microcapsule. Diabetologia 1988; 31: 54–57. 22 Darquy S., Reach G.. Immunoisolation of pancreatic B cells by microencapsulation: an in vitro study. Diabetologia 1985; 28: 776–780. 23 O'Shea GM, Goosen MFA, Sun AM. Prolonged survival of transplanted islets of Langerhans encapsulated iyn a biocompatible membrane. Biochim Biophys Acta 1984; 804: 133–136. 24 O'Shea GM, Sun AM. Encapsulation of rat islets prolongs xenograft survival in diabetic mice. Diabetes 1986; 35: 943–946. 25 Fan MY, Lum ZP, Fu XW, Levesque L., Tai IT, Sun AM. Reversal of diabetes in BB rats by transplantation of encapsulated pancreatic islets. Diabetes 1990; 39: 519–522. 26 Lum ZP, Tait IT, Krestaw M., Norton J., Vacek I., Sun AM. Prolonged reversal of the diabetic state in NOD mice by xenografts of microencapsulated rat islets. Diabetes 1991; 40: 1511–1516. 27 Calafiore R., Calcinaro F., Basta G., Pietropaolo M., Falorni A., Piermattei M., et al. A method for the massive separation of highly purified, adult porcine islets of Langerhans. Metabolism 1990; 39: 175–181. 28 Ricker AT, Stobetger SM, Halban PA, Eisenbarth GS, Bonner-Weir S.. Hyperimmune response to microencapsulated xenogenic tissue in non-obese diabetic mice. In: MA Jaworski, GD Molnar, RV Rajotte, B. Singh, eds. The Immunology of Diabetes Mellitus. Amsterdam: Elsevier, 1986. 193–200. 29 Chicheportiche D., Darquy S., Lepeintre J., Capron F., Halban PA, Reach G.. High-performance liquid chromatography analysis of circulating insulins distinguishes between endogenous insulin production (a potential pitfall with streptozotocin diabetic rats) and islet xenograft function. Diabetologia 1990; 33: 457–461. 30 Darquy S., Chicheportiche D., Capron F., Boitard C., Rouchette J., Reach G.. Comparative study of microencapsulated rat islets implanted in different diabetic models in mice. In: K. Federlin, RG Bretzel, BJ Hering, eds. Methods in Islet Transplantation Research. Stuttgart, New York: Georg Thieme Verlag, 1990. 209–213. 31 Mazaheri R., Atkison P., Stiller C., Dupré J., Vose J., O'Shea G.. Transplantation of encapsulated allogenic islets into diabetic BB/W rats. Effects of immunosuppression. Transplantation 1991; 51: 750–754. 32 Clayton HA, London NMJ, Colloby PS, James RFL, Bell PRF. The effect of capsule composition on the viability and biocompatibility of sodium alginate/poly-l-lysine encapsulated islets. Transplant Proc 1992; 24: 956. 33 Wolters GHJ, Fritschy WF, de Vos P., Van Schilfgaarde R.. Improvement of the biocompatibility of microencapsulated pancreatic islets. Diabetologia 1992; 35 (suppl 1): A190 (abstract). 34 Darquy S., Pueyo ME, Capron F., Reach G.. Activation of complement by alginate polylysine microcapsules (Abstract). Diabetologia 1990; 33: (suppl) A181. 35 Pueyo ME, Darquy S., Capron F., Reach G.. In vitro activation of human macrophages by alginate-polylysine microcapsules (Abstract). Diabetologia 1992; 35 (suppl 1): A188. 36 Cole DR, Waterfall M., McIntyre M., Baird JD. Microencap-sulated islet grafts in the BB/E rat: a possible role for cytokines in graft failure. Diabetologia 1992; 35: 231–237. 37 Sefton MV, Kharlip L., Horvath V., Roberts T.. Controlled release using microencapsulated mammalian cells. J of Controlled Release 1992; 19: 289–298. 38 Gin H., Dupuy B., Baquey A., Baquey Ch., Ducassou D. Lack of responsiveness to glucose of microencapsulated islets of Langerhans after three weeks' implantation in the rat—influence of the complement. Journal of Microencapsulation 1990; 7: 341–346. 39 Iwata H., Takagi T., Yamashita K., Kobayashi K., Amemiya H.. Allograft of microencapsulated islets on agarose gel in streptozotocin-induced and non-obese diabetic mice. Transplant Proc 1992; 24: 934. 40 Zekorn T., Siebers U., Horcher A., Schnettler R., Zimmermann U., Bretzel RG, et al. Alginate coating of islets of Langerhans: in vitro studies on a new method for microencapsulation for immuno-isolated transplantation. Acta Diabetol 1992; 29: 41–45. 41 Brown L., Munoz C., Siemer L., Edelman E., Langer R.. Controlled release of insulin from polymer matrices. Control of diabetes in rats. Diabetes 1986; 35: 692–697. 42 Kraegen EW, Chisholm DJ, MacNamara ME. Timing of insulin delivery with meals. Hormone and Metabolic Research 1981; 13: 365–369. 43 Fritschy WM, Strubbe JH, Wolters GHJ, Van Schilfgaarde R.. Glucose tolerance and plasma insulin response to intravenous glucose infusion and test meal in rats with microencapsulated islets. Diabetologia 1991; 34: 542–547. 44 Lum ZP, Krestow M., Tai IT, Vacek I., Sun AM. Xenografts of rat islets into diabetic mice. An evaluation of new smaller capsules. Transplantation 1992; 53: 1180–1183. 45 Archer J., Kaye R., Mutter G.. Control of streptozotocin diabetes in Chinese hamsters by culture mouse islet cells without immunosuppression: a preliminary report. J Surg Res 1980; 28: 77–85. 46 Altman JJ, Houlbert D., Callard P., McMillan P., Solomon BA, Rosen J., et al. Long-term plasma glucose normalization in experimental diabetic rats with macroencapsulated implants of benign human insulinoma. Diabetes 1986; 35: 625–633. 47 Icard P., Penfornis F., Gotheil C., Boillot J., Cornec C., Barrat F., et al. Tissue reaction to implanted bioartificial pancreas in pigs. Transplantation Proceedings 1990; 22: 724–726. 48 Zekorn T., Siebers U., Filip L., Mauer K., Schmitt U., Bretzel RG, et al. Bioartificial pancreas: the use of different hollow fibres as a diffusion chamber. Transplantation Proceedings 1989; 21: 2478–2750. 49 Lanza RP, Butler DH, Borland KM, Staruk JE, Faustman DL, Solomon BA, et al. Xenotransplantation of canine, bovine, and porcine islets in diabetic rats without immunosuppression. Proc Natl Acad Sci USA 1991; 88: 11100–11104. 50 Lacy PE, Hegre OD, Gerasimidi-Vazeou A., Gentile FT, Dionne KE. Maintenance of normoglycemia in diabetic mice by subcutaneous xenografts of encapsulated islets. Science 1991; 254: 1782–1784. 51 Lanza RP, Borland KM, Lodge P., Caretta M., Sullivan S., Muller T., Solomon BA, Maki T., Monaco AP, Chick WL. Treatment of severely diabetic pancreatectomized dogs using a diffusion-based hybrid pancreas. Diabetes 1992; 41: 886–889. 52 Chick WL, Like AA, Lauris V., Richardson PD, Panol G., Mix TW, Colton CK. A hybrid artificial pancreas. Trans Am Soc Artif Intern Organs 1975; 21: 8–13. 53 Tze W., Wong F., Chen L.. Implantable artificial capillary unit for pancreatic islet allograft and xenograft. Diabetologia 1979; 16: 247–252. 54 Orsetti A., Guy C., Zouari N., Deffay F.. Implantation du distributeur bio-artificiel d'insuline chez le chien utilisant des ilots d'espèce animale différente. Comptes Rendus de la Société de Biologie 1978; 172: 144–150. 55 Sun AM, Parisius W., Healy G., Vacek I., MacMorine H.. The use in diabetic rats and monkeys of artificial capillary units containing cultured islets of Langerhans (artificial endocrine pancreas). Diabetes 1977; 26: 1136–1139. 56 Reach G., Poussier Ph, Sausse A., Assan R., Itoh M., Gerich JE. Functional evaluation of a bioartificial pancreas using isolated islets perifused with blood ultrafiltrate. Diabetes 1981; 30: 296–301. 57 Reach G., Jaffrin MY. Kinetic modelling as a tool for the design of a vascular bioartificial pancreas: feedback between modelling and experimental validation. Computer Methods Prog Biomed 1990; 32: 277–285. 58 Reach G., Jaffrin MY, Desjeux JF. A U-shaped bioartificial pancreas with rapid glucose insulin kinetics: in vitro evaluation and kinetic modelling. Diabetes 1984; 33: 752–761. 59 Reach G., Chenard PS, Darquy S., Lepeintre J., Desjeux JF, Cannon R., Jaffrin MY. Bioartificial pancreas: in vivo evaluation in conscious normal rats. In Y. Nosé, C. Kjelllstrand, P. Ivanovich, eds. Progress in Artificial Organs—1985. Cleveland: ISAO Press, 1986: 621–626. 60 Lepeintre J., Briandet H., Moussy F., Chicheportiche D., Darquy S., Rouchette J., et al. Ex vivo evaluation in normal dogs of insulin release by a bioartificial pancreas containing isolated rat islets of Langerhans. Artificial Organs 1990; 14: 20–27. 61 Reach G., Jaffrin MY. Bioartificial pancreas as an approach to closed-loop insulin delivery. In: WD Emsinger, JL Selam, eds. Drug Delivery Systems. Mount Kisco, New York: Futura, 1987. 99–102. 62 Sullivan SJ, Maki T., Borland KM, Mahoney MD, Solomon BA, Muller TE, et al. Biohybrid artificial pancreas: long term implantation studies in diabetic, pancreatectomized dogs. Science 1991; 252: 718–721. 63 Monaco AP, Maki T., Ozato H., Carretta M., Sullivan SJ, Borland KM, et al. Transplantation of islet allografts and xenografts in totally pancreatectomized dogs using the hybrid artificial pancreas. Annals of Surgery 1991; 214: 339–360. 64 Ohzato H., Carretta M., Maki T., Sullivan SJ, Borland K., Muller TE, et al. Use of xenogeneic islets in hybrid artificial pancreas for treatment of diabetes without immunosuppression. Transplant Proc 1992; 24: 661–664. 65 Calafiore R., Basta G., Falorni A., Ciabattoni P., Brotzu G., Cortesini R., et al. Intravascular transplantation of microencapsulated islets in diabetic dogs. Transplant Proc 1992; 24: 935–936. 66 Calafiore R.. Transplantation of microencapsulated pancreatic human islets for therapy of diabetes mellitus: a preliminary report. Am Soc Artif Intern Organs J 1992; 38: 34–37. Citing Literature Volume10, Issue2March 1993Pages 105-109 ReferencesRelatedInformation
Referência(s)